250 related articles for article (PubMed ID: 25146483)
41. Identification of the epitope in human poliovirus type 1 Sabin strain recognized by the monoclonal antibody 1G10 using mimotope strategy.
Bai H; Liu S; Shi S; Lu W; Yang Y; Zhu Y; Zhang Z; Guo H; Li X
J Virol Methods; 2020 Feb; 276():113791. PubMed ID: 31778678
[TBL] [Abstract][Full Text] [Related]
42. An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex.
Venkatramani L; Bochkareva E; Lee JT; Gulati U; Graeme Laver W; Bochkarev A; Air GM
J Mol Biol; 2006 Feb; 356(3):651-63. PubMed ID: 16384583
[TBL] [Abstract][Full Text] [Related]
43. Using a combined computational-experimental approach to predict antibody-specific B cell epitopes.
Sela-Culang I; Benhnia MR; Matho MH; Kaever T; Maybeno M; Schlossman A; Nimrod G; Li S; Xiang Y; Zajonc D; Crotty S; Ofran Y; Peters B
Structure; 2014 Apr; 22(4):646-57. PubMed ID: 24631463
[TBL] [Abstract][Full Text] [Related]
44. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
Sawyer LA; McInnis J; Albrecht P
Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
[TBL] [Abstract][Full Text] [Related]
45. Induced pocket to accommodate the cell attachment Arg-Gly-Asp motif in a neutralizing antibody against foot-and-mouth-disease virus.
Verdaguer N; Mateu MG; Bravo J; Domingo E; Fita I
J Mol Biol; 1996 Feb; 256(2):364-76. PubMed ID: 8594203
[TBL] [Abstract][Full Text] [Related]
46. Evidence for several unrelated neutralization epitopes of poliovirus, type 1, strain Mahoney, provided by neutralization tests and quantitative enzyme-linked immunosorbent assay (ELISA).
Uhlig H; Rutter G; Dernick R
J Gen Virol; 1983 Dec; 64 ( Pt 12)():2809-12. PubMed ID: 6198443
[TBL] [Abstract][Full Text] [Related]
47. Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains.
Tano Y; Shimizu H; Martin J; Nishimura Y; Simizu B; Miyamura T
Vaccine; 2007 Oct; 25(41):7041-6. PubMed ID: 17825459
[TBL] [Abstract][Full Text] [Related]
48. Mapping of type 1 poliovirus neutralization epitopes.
Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
[TBL] [Abstract][Full Text] [Related]
49. Mapping of antigenic domains in poliovirus VP1 involved in structural rearrangements during virus morphogenesis and antigenic alterations of the virion.
Ketterlinus R; Wiegers K
Virology; 1994 Oct; 204(1):27-37. PubMed ID: 7522372
[TBL] [Abstract][Full Text] [Related]
50. Studies of the antigenic variation in poliovirus type 1. Selection and analysis of variant strains with monoclonal antibodies by neutralization.
Thibodeau L; Lacroix M; Lecomte J; Fauvel M
Dev Biol Stand; 1984; 57():157-63. PubMed ID: 6084606
[TBL] [Abstract][Full Text] [Related]
51. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
Julien JP; Bryson S; Nieva JL; Pai EF
J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005
[TBL] [Abstract][Full Text] [Related]
52. Monoclonal antibodies reveal in blocking reactions the antigenicity and antibody response of poliovirus.
Uhlig H; Rutter G; Dernick R
Dev Biol Stand; 1984; 57():187-91. PubMed ID: 6084610
[TBL] [Abstract][Full Text] [Related]
53. Conformational shift of a major poliovirus antigen confirmed by immuno-cryogenic electron microscopy.
Lin J; Cheng N; Hogle JM; Steven AC; Belnap DM
J Immunol; 2013 Jul; 191(2):884-91. PubMed ID: 23772035
[TBL] [Abstract][Full Text] [Related]
54. The stoichiometry of binding between monoclonal antibody molecules and the hemagglutinin of influenza virus.
Poumbourios P; Brown LE; White DO; Jackson DC
Virology; 1990 Dec; 179(2):768-76. PubMed ID: 1700542
[TBL] [Abstract][Full Text] [Related]
55. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.
Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M
Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609
[TBL] [Abstract][Full Text] [Related]
56. Antigenic structure of chimeras of type 1 and type 3 polioviruses involving antigenic sites 2, 3 and 4.
Minor PD; Ferguson M; Katrak K; Wood D; John A; Howlett J; Dunn G; Burke K; Almond JW
J Gen Virol; 1991 Oct; 72 ( Pt 10)():2475-81. PubMed ID: 1717641
[TBL] [Abstract][Full Text] [Related]
57. Fab'-induced folding of antigenic N-terminal peptides from intrinsically disordered HIV-1 Tat revealed by X-ray crystallography.
Serrière J; Dugua JM; Bossus M; Verrier B; Haser R; Gouet P; Guillon C
J Mol Biol; 2011 Jan; 405(1):33-42. PubMed ID: 21035463
[TBL] [Abstract][Full Text] [Related]
58. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
Roehrig JT; Bolin RA; Kelly RG
Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
[TBL] [Abstract][Full Text] [Related]
59. Neutralization epitope patterns of poliovirus strains isolated from paralytic cases.
Crainic R; Blondel B; Aubert-Combiescu A; Beytout D; Couillin P; Candrea A; Boué A; Horaud F
Dev Biol Stand; 1984; 57():165-70. PubMed ID: 6084607
[TBL] [Abstract][Full Text] [Related]
60. Structure of Parvovirus B19 Decorated by Fabs from a Human Antibody.
Sun Y; Klose T; Liu Y; Modrow S; Rossmann MG
J Virol; 2019 May; 93(9):. PubMed ID: 30787153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
